Expression of the Leukocyte Early Activation Antigen CD69 Is Regulated by the Transcription Factor AP-1

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5463-5473

  Castellanos, María Del Carmen ^a   Muñoz, Cecilia ^a   Montoya, María C ^a   Lara Pezzi, Enrique ^a   López Cabrera, Manuel ^a   De Landázuri, Manuel O ^a,b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; LEUKOCYTE ANTIGEN; MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN; T LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR AP 1;

ANIMAL; ARTICLE; CELL CULTURE; CONSENSUS SEQUENCE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; LEUKEMIA CELL LINE; METABOLISM; MOLECULAR GENETICS; MOUSE; MUTATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BASE SEQUENCE; CONSENSUS SEQUENCE; GENE EXPRESSION REGULATION; HUMANS; JURKAT CELLS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0031298114     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Ullman, K. S., J. P. Northrop, C. L. Verweij, and G. R. Crabtree. 1990. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8:421.
2. Cebrián, M., E. Yagüe, M. Rincón, M. López-Botet, M. O. de Landázuri, and F. Sánchez-Madrid. 1988. Triggering of T cell proliferation through AIM, an activation inducer molecule expressed on activated human lymphocytes. J. Exp. Med. 168:1621.
3. Hara, T., L. K. L. Jung, J. M. Bjorndahl, and S. M. Fu. 1986. Human T cell activation. III. Rapid induction of a phosphorylated 28kD/32kD disulfide-linked early activation antigen (EA1) by 12-O-tetradecanoyl phorbol-13-acetate, mitogens and antigens. J. Exp. Med. 164:1988.
4. Sánchez-Mateos, P., M. Cebrián, A. Acevedo, M. López-Botet, M. O. de Landázuri, and F. Sánchez-Madrid. 1989. Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues: induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies. Immunology 68:72.
5. Sánchez-Mateos, P., and F. Sánchez-Madrid. 1991. Structure-function relationship and immunochemical mapping of external and intracellular antigenic sites on the lymphocyte activation inducer molecule, AIM/CD69. Eur. J. Immunol. 21: 2317.
6. Hartnell, A., D. S. Robinson, A. B. Kay, and A. J. Wardlaw. 1993. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines. Immunology 80:281.
7. Lanier, L. L., D. W. Buck, L. Rhodes, A. Ding, E. Evans, C. Barney, and J. H. Phillips. 1988. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J. Exp. Med. 167:1572.
8. Laffón, A., R. García-Vicuña, A. Humbría, A. A. Postigo, A. L. Corbí, M. O. de Landázuri, and F. Sánchez-Madrid. 1991. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J. Clin. Invest. 88:546.
9. + T lymphocytes in viral chronic active hepatitis. Gastroenterology 98:1029.
10. Nakamura, S., S. J. Sung, J. M. Bjorndahl, and S. M. Fu. 1989. Human T cell activation: T cell activation and proliferation via the early activation antigen EA 1. J. Exp. Med. 169:677.
11. Santis, A. G., M. R. Campanero, J. L. Alonso, A. Tugores, M. A. Alonso, E. Yagüe, J. P. Pivel, and F. Sánchez-Madrid. 1992. Tumor necrosis factor-α production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur. J. Immunol. 22:1253.
12. Testi, R., J. H. Phillips, and L. L. Lanier. 1989. T cell activation via Leu-23 (CD69). J. Immunol. 143:1123.
13. Tugores, A., A. L. Alonso, F. Sánchez-Madrid, and M. O. de Landázuri. 1992. Human T cell activation through the activation inducer molecule/CD69 enhances the activity of transcription factor AP-1. J. Immunol. 148:2300.
14. Moretta, A., A. Poggi, D. Pende, G. Tripodi, A. M. Orengo, N. Pella, R. Augugliaro, C. Bottino, E. Ciccone, and L. Moretta. 1991. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor α/β. J. Exp. Med. 174:1393.
15. Testi, R., F. Pulcinelli, L. Frati, P. P. Gazzaniga, and A. Santoni. 1990. CD69 is expressed on platelets and mediates platelet activation and aggregation. J. Exp. Med. 172:701.
16. Testi, R., D. D'Ambrosio, R. De María, and A. Santoni. 1994. The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol. Today 15:479.
17. De María, R., M. G. Cifone, R. Trotta, M. R. Rippo, C. Fetuccia, A. Santoni, and R. Testi. 1994. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 180:1999.
18. Hamman, J., H. Fiebig, and M. Strauss. 1993. Expression cloning of the early activation antigen CD69, a type II integral membrane protein with a C-type lectin domain. J. Immunol. 150:4920.
19. López-Cabrera, M., A. G. Santis, E. Fernandez-Ruiz, R. Blacher, F. Esch, P. Sánchez-Mateos, and F. Sánchez-Madrid. 1993. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178:537.
20. Ziegler, S. F., F. Ramsdell, K. A. Hjerrild, R. J. Armitage, K. H. Grabstein, K. B. Hennen, T. Farrah, W. C. Fanslow, E. M. Shevach, and M. R. Alderson. 1993. Molecular characterization of the early activation antigen CD69: a type II membrane glycoprotein related to a family of natural killer cell activation antigens. Eur. J. Immunol. 23:1643.
21. Santis, A. G., M. López-Cabrera, J. Hamann, M. Strauss, and F. Sánchez-Madrid. 1994. Structure of the gene coding for the human early lymphocyte activation antigen CD69: a C-type lectin receptor evolutionarily related with the gene families of natural killer cell-specific receptors. Eur. J. Immunol. 24:1692.
22. Ziegler, S. F., S. D. Levin, L. Johnson, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, E. Baker, G. R. Sutherland, A. L. Feldhaus, and F. Ramsdell. 1994. The mouse CD69 gene: structure, expression, and mapping to the NK gene complex. J. Immunol. 152:1228.
23. López-Cabrera, M., E. Muñoz, M. V. Blázquez, M. A. Ursa, A. G. Santis, and F. Sánchez-Madrid. 1995. Transcriptional regulation of the gene encoding the human C-type lectin leukocyte receptor AIM/CD69 and functional characterization of its tumor necrosis factor-α-responsive elements. J. Biol. Chem. 270:21545.
24. Karin, M., and T. Smeal. 1992. Control of transcription factors by signal transduction pathways: the beginning of the end. Trends Biochem. Sci. 17:418.
25. Angel, P., and M. Karin. 1991. The role of Jun, Fos, and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta 1072:129.
26. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483.
27. Schulze-Osthoff, K., H. Schenk, and W. Dröge. 1995. The effects of thioredoxin on activation of transcription factor NF-kappaB. Methods Enzymol. 252:253.
28. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:2005.
29. Brenner, D. A., M. O'Hara, P. Angel, M. Chojkier, and M. Karin. 1989. Prolonged activation of jun and collagenase genes by tumor necrosis factor-α. Nature 337:661.
30. Aragonés, J., C. López-Rodriguez, A. Corbí, P. Gómez del Arco, M. López-Cabrera, M. O. de Landázuri, and J. M. Redondo. 1996. Dithiocarbamates trigger differentiation and induction of CD11c gene through AP-1 in the myeloid lineage. J. Biol. Chem. 271:10924.
31. Schreck, R., B. Meier, D. N. Männel, W. Droge, and P. A. Bauerle. 1992. Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J. Exp. Med. 175:1181.
32. Sánchez-Madrid, F., M. L. Toribio, F. Gambón, and M. O. de Landázuri. 1985. Cell surface molecular changes on the activation of human thymocytes. J. Immunol. 135:3938.
33. Pulido, R., M. J. Elices, M. R. Campanero, L. Osborn, S. Schiffer, A. García-Pardo, R. Lobb, M. E. Hemler, and F. Sánchez-Madrid. 1991. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4: correlation with distinct alpha 4 epitopes. J. Biol. Chem. 266:10241.
34. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294.
35. López-Cabrera, M., A. Nueda, A. Vara, J. G. García-Aguilar, A. Tugores, and A. L. Corbi. 1993. Characterization of the p150,95 leukocyte integrin alpha subunit (CD11c) gene promoter: identification of cis-acting elements. J. Biol. Chem. 268:1187.
36. Schreiber, E., P. Matthias, M. M. Muller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 17:6419.
37. López-Rodriguez, C., H. C. Kluin-Nelemans, and A. L. Corbí. 1996. AP-1 regulates the basal and developmentally induced transcription of the CD11c leukocyte integrin gene. J. Immunol. 156:3780.
38. Chiu, R., P. Angel, and M. Karin. 1989. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 59:979.
39. Petrak, D., S. A. Memon, M. J. Birrer, J. D. Ashwell, and C. M. Zacharchuk. 1994. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription. J. Immunol. 153:2046.
40. Schulze-Osthoff, K., M. Los, and P. A. Bauerle. 1995. Redox signalling by transcription factors NF-κB and AP-1 in lymphocytes. Biochem. Pharmacol. 50:735.
41. 2-terminal kinase) is a target for antioxidants in T lymphocytes. J. Biol. Chem. 271:26335.
42. Brown, P. H., R. Alani, L. H. Preis, E. Szabo, and M. J. Birrer. 1993. Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8:887.
43. Brown, P. H., T. K. Chen, and M. J. Birrer. 1994. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9:791.
44. Brown, P. H., S. H. Kim, A. L. Sabichi, and M. J. Birrer. 1996. Dominant-negative mutants of cJun inhibit AP-1 activity through multiple mechanisms and with different potencies. Cell Growth Differ. 7:1013.
45. ras activation in T cell CD69 expression. Eur. J. Immunol. 24:616.
46. Taylor-Fishwick, D. A., and J. N. Siegel. 1995. Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells. Eur. J. Immunol. 25:3215.
47. Cockerill, P. N., A. G. Bert, F. Jenkins, G. R. Ryan, M. F. Shannon, and M. A. Vadas. 1995. Human granulocyte-macrophage colony-stimulating factor enhancer function is associated with cooperative interactions between AP-1 and NFATp/c. Mol. Cell. Biol. 15:2071.
48. Peterson, B. R., L. J. Sun, and G. L. Verdine. 1996. A critical arginine residue mediates cooperativity in the contact interface between transcription factors NFAT and AP-1. Proc. Natl. Acad. Sci. USA 93:13671.
49. Bassuk, A. G., and J. M. Leiden. 1995. A direct physical association between ETS and AP-1 transcription factors in normal human T cells. Immunity 3:223.
50. Jain, J., P. G. McCaffrey, V. E. Valge-Archer, and A. Rao. 1992. Nuclear factor of activated T cells contains Fos and Jun. Nature 356:801.
51. Northrop, J. P., K. S. Ullman, and G. R. Crabtree. 1993. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T-cells (NF-AT) complex. J. Biol. Chem. 268:2917.
52. Boise, L. H., B. Petryniak, X. Mao, C. H. June, C. Y. Wang, T. Lindsten, R. Bravo, K. Kovary, J. M. Leiden, and C. B. Thompson. 1993. The NFAT DNA binding complex in activated T cells contains Fra-1 and JunB. Mol. Cell. Biol. 13:1911.
53. Hodge, M. R., A. M. Ranger, F. C. Brousse, T. Hoey, M. J. Grusby, and M. J. Glimcher. 1996. Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4:397.
54. Bauerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141.
55. Bauerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13.
56. Takahiro, S. D., T. Takahashi, O. Taguchi, T. Azuma, and Y. Obata. 1997. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953.
57. Anrather, J., V. Csizmadia, C. Brostjan, M. P. Soares, F. H. Bach, and H. Winkler. 1997. Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-κB. J. Clin. Invest. 99: 763.
58. Boothby, M. R., A. L. Mora, D. C. Scherer, J. A. Brockman, and D. W. Ballard. 1997. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive represser of nuclear factor NF-κB. J. Exp. Med. 185:1897.
59. Muñoz, C., M. C. Castellanos, A. Alfranca, A. Vara, M. A. Esteban, J. M. Redondo, and M. O. de Landázuri. 1996. Transcriptional up-regulation of intracellular adhesion molecule-1 in human endothelial cells by the antioxidant pyrrolidine dithiocarbamate involves the activation of activating protein-1. J. Immunol. 157:3587.
60. Muñoz, C., D. Pascual-Salcedo, M. C. Castellanos, A. Alfranca, J. Aragonés, A. Vara, J. M. Redondo, and M. O. de Landázuri. 1996. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-κB and AP-1 transcription factors activity. Blood 88:3482.
61. Staal, F. J. T., M. Roederer, L. A. Herzenberg, and L. A. Herzenberg. 1990. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 87:9943.
62. Schreck, R., P. Rieber, and P. A. Bauerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247.
63. Crabtree, G. R. 1989. Contingent genetic regulatory events in T lymphocyte activation. Science 243:355.
64. Sheng, M., S. T. Dougan, G. McFadden, and M. E. Greenberg. 1988. Calcium and growth factor pathways of c-fos transcriptional activation require distinct upstream regulatory sequences. Mol. Cell. Biol. 8:2787.
65. Lemaire, P., O. Revelant, R. Bravo, and P. Charnay. 1988. Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc. Natl. Acad. Sci. USA 85:4691.
66. Santis, A. G., M. López-Cabrera, F. Sánchez-Madrid, and N. Proudfoot. 1995. Expression of the early lymphocyte activation antigen CD69, a c-type lectin, is regulated by mRNA degradation associated with AU-rich sequence motifs. Eur. J. Immunol. 25:2142.